These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21996984)

  • 21. The effect of combined calcium and vitamin D3 supplementation on serum intact parathyroid hormone in moderate CKD.
    Kooienga L; Fried L; Scragg R; Kendrick J; Smits G; Chonchol M
    Am J Kidney Dis; 2009 Mar; 53(3):408-16. PubMed ID: 19185400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin D supplementation and bone turnover in advanced heart failure: the EVITA trial.
    Zittermann A; Ernst JB; Prokop S; Fuchs U; Dreier J; Kuhn J; Berthold HK; Pilz S; Gouni-Berthold I; Gummert JF
    Osteoporos Int; 2018 Mar; 29(3):579-586. PubMed ID: 29260292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholecalciferol Additively Reduces Serum Parathyroid Hormone and Increases Vitamin D and Cathelicidin Levels in Paricalcitol-Treated Secondary Hyperparathyroid Hemodialysis Patients.
    Zheng JQ; Hou YC; Zheng CM; Lu CL; Liu WC; Wu CC; Huang MT; Lin YF; Lu KC
    Nutrients; 2016 Nov; 8(11):. PubMed ID: 27827962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monthly cholecalciferol administration in haemodialysis patients: a simple and efficient strategy for vitamin D supplementation.
    Jean G; Souberbielle JC; Chazot C
    Nephrol Dial Transplant; 2009 Dec; 24(12):3799-805. PubMed ID: 19622574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modified-release oral calcifediol corrects vitamin D insufficiency with minimal CYP24A1 upregulation.
    Petkovich M; Melnick J; White J; Tabash S; Strugnell S; Bishop CW
    J Steroid Biochem Mol Biol; 2015 Apr; 148():283-9. PubMed ID: 25446887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholecalciferol supplementation increases FGF23 in peritoneal dialysis patients with hypovitaminosis D: a randomized clinical trial.
    Ramirez-Sandoval JC; Arvizu-Hernandez M; Cruz C; Vazquez-Cantu B; Rojas-Concha LJ; Tamez L; Reynerio F; Gomez FE; Correa-Rotter R
    J Nephrol; 2019 Aug; 32(4):645-659. PubMed ID: 30888584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers.
    Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
    Nephrol Dial Transplant; 2008 Nov; 23(11):3670-6. PubMed ID: 18579534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of ergocalciferol supplementation on serum parathyroid hormone and serum 25-hydroxyvitamin D in chronic kidney disease.
    DeVille J; Thorp ML; Tobin L; Gray E; Johnson ES; Smith DH
    Nephrology (Carlton); 2006 Dec; 11(6):555-9. PubMed ID: 17199797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of weekly administration of cholecalciferol on parathyroid hormone in stable kidney-transplanted patients with CKD stage 1-3.
    Sella S; Bonfante L; Fusaro M; Neri F; Plebani M; Zaninotto M; Aghi A; Innico G; Tripepi G; Michielin A; Prandini T; Calò LA; Giannini S
    Clin Chem Lab Med; 2020 May; 59(2):343-351. PubMed ID: 32374278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholecalciferol in haemodialysis patients: a randomized, double-blind, proof-of-concept and safety study.
    Delanaye P; Weekers L; Warling X; Moonen M; Smelten N; Médart L; Krzesinski JM; Cavalier E
    Nephrol Dial Transplant; 2013 Jul; 28(7):1779-86. PubMed ID: 23378417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency.
    Leventis P; Kiely PD
    Scand J Rheumatol; 2009; 38(2):149-53. PubMed ID: 18991184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin D insufficiency and treatment with oral vitamin D3 in northern-dwelling patients with chronic kidney disease.
    Rucker D; Tonelli M; Coles MG; Yoo S; Young K; McMahon AW
    J Nephrol; 2009; 22(1):75-82. PubMed ID: 19229821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysis.
    Greenbaum LA; Benador N; Goldstein SL; Paredes A; Melnick JZ; Mattingly S; Amdahl M; Williams LA; Salusky IB
    Am J Kidney Dis; 2007 Jun; 49(6):814-23. PubMed ID: 17533024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral cholecalciferol decreases albuminuria and urinary TGF-β1 in patients with type 2 diabetic nephropathy on established renin-angiotensin-aldosterone system inhibition.
    Kim MJ; Frankel AH; Donaldson M; Darch SJ; Pusey CD; Hill PD; Mayr M; Tam FW
    Kidney Int; 2011 Oct; 80(8):851-60. PubMed ID: 21832985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of FGF-23 mediated vitamin D degradative pathways by cholecalciferol.
    Alshayeb H; Showkat A; Wall BM; Gyamlani GG; David V; Quarles LD
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E1830-7. PubMed ID: 24960544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Cholecalciferol therapy on serum FGF
    Kamelian T; Saki F; Jeddi M; Dabbaghmanesh MH; Omrani GHR
    J Endocrinol Invest; 2018 Mar; 41(3):299-306. PubMed ID: 28795342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is high-dose cholecalciferol justified in children with chronic kidney disease who failed low-dose maintenance therapy?
    Kari JA; Baghdadi OT; El-Desoky S
    Pediatr Nephrol; 2013 Jun; 28(6):933-7. PubMed ID: 23338053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of a short course of very-high-dose cholecalciferol in hemodialysis.
    Wasse H; Huang R; Long Q; Singapuri S; Raggi P; Tangpricha V
    Am J Clin Nutr; 2012 Feb; 95(2):522-8. PubMed ID: 22237061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparisons between oral pulse alfacalcidol therapy and daily therapy in maintenance hemodialysis patients with secondary hyperparathyroidism: a randomized, controlled, and multicenter study.
    Gu Y; Ding F; Chen N; Mei CL; Qian JQ; Wang XY; Shi W; Hou FF; Li XW; Wang M; Chen YP
    Ren Fail; 2005; 27(2):205-12. PubMed ID: 15807187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.